2m 2m 2m 2m 2m 2m 2m
Alterola Biotech (ABTI)
OTC
$0.0002-$0.005 (-96.08%)
Price as of Jul 14, 2026- $291,900.00Market Cap
- 0.00%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Alterola Biotech (ABTI)
$0.0002-$0.005 (-96.08%)
ABTI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.00 | ||
Change | -$0.005 (-96.08%) | ||
Open | $0.00 | ||
High | $0.00 | ||
Low | $0.00 | ||
Previous Close | $0.01 | ||
Volume | 5,000 | ||
30-Day Average Volume | 5,000 | ||
1-Week Change | -96.08% | ||
1-Month Change | -96.08% | ||
1-Year Change | 0.00% | ||
3-Year Change | -98.18% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 1.5B | ||
Total Assets | $1.4M | ||
Market Cap | $291,900.00 | ||
Enterprise Value | $2.6M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$799,193.00 | ||
Free Cash Flow | -$860,566.00 | ||
EBIT | -$461,896.00 | ||
EBITDA | -$461,896.00 | ||
Net Working Capital | -$2.5M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -6 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -0 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -0 | ||
Price/Operating Cash Flow | -0 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||